ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08905
-0,04%
Bitcoin
67.160,98
0,33%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Mustang Bio Inc (MBIO)

  7. Mustang Bio Inc (MBIO) News

MBIO

Mustang Bio (MBIO)

Mustang Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MBIO
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202412h01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBIOMustang Bio Inc
02/05/202422h01GlobeNewswire Inc.Mustang Bio Announces Closing of $4 Million Public OfferingNASDAQ:MBIOMustang Bio Inc
30/04/202402h00GlobeNewswire Inc.Mustang Bio Announces Pricing of $4 Million Public OfferingNASDAQ:MBIOMustang Bio Inc
28/03/202414h00GlobeNewswire Inc.Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune DiseasesNASDAQ:MBIOMustang Bio Inc
11/03/202421h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
11/03/202421h05GlobeNewswire Inc.Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:MBIOMustang Bio Inc
11/03/202421h02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MBIOMustang Bio Inc
07/03/202413h30GlobeNewswire Inc.Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade GliomaNASDAQ:MBIOMustang Bio Inc
14/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
25/01/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
11/01/202414h30GlobeNewswire Inc.Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology ConferenceNASDAQ:MBIOMustang Bio Inc
04/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
19/12/202322h06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
12/12/202303h52Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
11/12/202314h37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
11/12/202314h30GlobeNewswire Inc.Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual MeetingNASDAQ:MBIOMustang Bio Inc
14/11/202322h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
14/11/202322h05GlobeNewswire Inc.Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:MBIOMustang Bio Inc
03/11/202320h22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:MBIOMustang Bio Inc
02/11/202321h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
02/11/202314h28GlobeNewswire Inc.Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:MBIOMustang Bio Inc
30/10/202319h57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
30/10/202319h15GlobeNewswire Inc.Mustang Bio Announces Closing of $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:MBIOMustang Bio Inc
30/10/202315h30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBIOMustang Bio Inc
26/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
26/10/202318h30GlobeNewswire Inc.Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:MBIOMustang Bio Inc
26/10/202315h00GlobeNewswire Inc.Mustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade AstrocytomaNASDAQ:MBIOMustang Bio Inc
04/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
16/08/202314h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
14/08/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
 Showing the most relevant articles for your search:NASDAQ:MBIO

Kürzlich von Ihnen besucht

AMEX
JJE
iPath Series B Bloomberg...
TG
N4G
Naga
ASX
ANON
TSX
NFAM
NBI Canadian Family Busi...
AMEX
UXP
U.S. Exploration
COIN
MUSEETH
Muse DAO
UNSW3
BIDETH
Bidao
TSXV
GTR
Gatling Exploration
BIT
UB7HQJ
Unicredit Bank
NASDAQ
AAWPXXX
Citigroup Global Markets...
GATE
BNTUSDT
Bancor
BTRX
SPWNUSDT
BitSpawn Token
GATE
IONXETH
Charged Particles - IONX
COIN
BAYEUR
BitBay
LSE
61AE
Sant Uk Grp 27
LSE
GUN
Gunsynd
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten